MUMBAI, India, May 9 -- Intellectual Property India has published a patent application (202321075088 A) filed by Indian Institute Of Technology, Indore, Madhya Pradesh, on Nov. 3, 2023, for 'novel compound and method thereof to address the tirap mediated chronic inflammatory signalling.'
Inventor(s) include Dr. Mirza S. Baig; and Rajat Atre.
The application for the patent was published on May 9, under issue no. 19/2025.
According to the abstract released by the Intellectual Property India: "The present invention provides a novel compound ANTINFLA to address the TIRAP mediated chronic inflammatory signaling. The present invention offers the possibility of preventing TIRAP- PKCd-BTK interaction to reduce macrophage inflammatory signals and...